Related Subjects:
| Meningococcal Meningitis
| Pneumococcal Meningitis
| Listerial Meningitis
|Herpes Simplex Encephalitis (HSV)
|Acute Encephalitis
|Toxoplasmosis
|Lumbar Puncture
|CSF Interpretation
|Tuberculosis
|TB Meningitis
|Chronic and recurrent Meningitis
๐ง Introduction
- Chronic meningitis is inflammation of the meninges causing symptoms that persist for โฅ4 weeks.
- Recurrent meningitis describes โฅ2 distinct episodes of meningitis, usually with CSF pleocytosis, separated by complete or near-complete clinical recovery.
- Unlike acute meningitis, chronic meningitis usually develops gradually over days to weeks and may follow a fluctuating course.
- Important causes include infection, malignancy and inflammatory/autoimmune disease.
- โ ๏ธ The diagnosis can be difficult: conventional investigations may fail to identify a cause, and repeated CSF sampling or tissue biopsy may occasionally be required.
๐ก Think broadly: the major diagnostic groups are infectious, inflammatory/autoimmune and neoplastic.
In recurrent bacterial meningitis, specifically look for a CSF leak, skull-base defect or immune deficiency.
๐ฆ Causes
- Infectious causes:
- ๐งซ Mycobacterial: Mycobacterium tuberculosis โ one of the most important causes worldwide.
- ๐ Fungal: Cryptococcus neoformans and C. gattii; endemic fungi such as Histoplasma or Coccidioides depending on travel/geographical exposure.
- ๐ Spirochaetal: Treponema pallidum (neurosyphilis) and Borrelia burgdorferi (neuroborreliosis).
- ๐งช Other bacteria: Brucella, Leptospira and occasionally other indolent bacterial infections.
- ๐ฆ Viral: HIV itself may produce a chronic aseptic meningitis; HSV-2 is particularly associated with recurrent lymphocytic meningitis (Mollaret meningitis).
- ๐ชฑ Parasitic: selected parasitic infections may cause chronic or eosinophilic meningitis, depending on exposure and geography.
- Inflammatory / autoimmune causes:
- ๐ฅ Neurosarcoidosis.
- ๐ฅ Behรงet disease.
- ๐ฅ Systemic lupus erythematosus.
- ๐ฅ ANCA-associated vasculitis and other CNS vasculitides.
- ๐ฅ IgG4-related disease and other inflammatory pachymeningitides.
- Neoplastic causes:
- ๐๏ธ Leptomeningeal metastases โ particularly breast cancer, lung cancer and melanoma.
- ๐๏ธ Lymphoma and leukaemia involving the meninges.
- Other causes:
- ๐ Drug-induced aseptic meningitis โ e.g. NSAIDs, IV immunoglobulin and some antimicrobials.
- ๐ง Chemical meningitis โ e.g. following neurosurgery or rupture of an epidermoid/dermoid cyst.
๐ Recurrent Meningitis โ Important Causes
- ๐ฆ HSV-2: the commonest recognised cause of recurrent aseptic meningitis (Mollaret meningitis).
- ๐ Skull-base or CSF leak: congenital or acquired defects may allow recurrent pneumococcal or other bacterial meningitis.
- ๐ Look for previous head trauma, neurosurgery, chronic ear disease or sinus disease.
- ๐ก๏ธ Consider immune deficiency, particularly complement deficiency, antibody deficiency or functional/anatomical asplenia in recurrent bacterial infection.
๐งฉ Clinical clue: recurrent pneumococcal meningitis should prompt a search for a CSF leak or skull-base defect.
Recurrent meningococcal disease should raise suspicion of terminal complement deficiency.
๐ฉบ Clinical Features
- ๐ค Headache โ often persistent and progressive.
- ๐ก๏ธ Fever may be present, although it may be low-grade or absent.
- ๐ด Malaise, lethargy, anorexia and weight loss may occur.
- ๐ก Photophobia, neck stiffness and other classical meningeal signs may be mild or absent.
- ๐๏ธ Cranial neuropathies are important, particularly with basal meningitis such as TB, cryptococcosis or malignancy.
- โก Seizures, altered cognition or reduced consciousness may develop.
- ๐ฆต Focal neurological deficits may reflect vasculitis, infarction, hydrocephalus or focal lesions.
- ๐ Look for systemic clues such as rash, lymphadenopathy, pulmonary disease, uveitis, arthritis or malignancy.
๐งช Investigations
โ ๏ธ Before lumbar puncture: assess for contraindications and consider urgent neuroimaging when there are focal neurological signs, markedly impaired consciousness, papilloedema, seizures or concern about a mass lesion / obstructed CSF circulation.
- ๐ฉธ Blood tests:
- FBC, U&E, LFTs, CRP/ESR and blood cultures where infection is suspected.
- HIV test should usually be included.
- Syphilis serology ยฑ Lyme serology according to clinical and epidemiological risk.
- TB testing and investigation for extracranial TB where appropriate.
- Autoimmune investigations should be guided by the clinical phenotype rather than indiscriminately screening with ANA/ANCA/ACE.
- ๐ Lumbar puncture / CSF:
- ๐ Record the opening pressure.
- Cell count and differential.
- Protein and paired CSF/blood glucose.
- Gram stain and bacterial culture.
- Mycobacterial microscopy, culture and nucleic-acid testing where TB is suspected.
- Fungal culture and cryptococcal antigen when appropriate.
- HSV/VZV and other PCR tests according to the clinical presentation.
- Syphilis testing and other targeted microbiology according to exposure.
- ๐ฌ Cytology ยฑ flow cytometry when leptomeningeal malignancy or lymphoma is suspected.
- ๐ง Imaging:
- Contrast-enhanced MRI brain is generally the preferred imaging investigation.
- Possible findings include basal or leptomeningeal enhancement, hydrocephalus, infarction, tuberculomas, cryptococcomas or neoplastic deposits.
- Consider MRI spine if there are spinal symptoms or suspected leptomeningeal disease.
- CT chest/abdomen/pelvis ยฑ PET-CT may help identify occult malignancy, sarcoidosis or a focus of TB.
- ๐ฌ Further investigation:
- Repeated large-volume CSF samples may increase diagnostic yield, particularly for malignancy or TB.
- Biopsy of an accessible lymph node, skin lesion or other abnormal tissue is preferable to meningeal biopsy where possible.
- Meningeal/brain biopsy may occasionally be required when extensive investigation remains non-diagnostic.
๐ Typical CSF Patterns
| Cause |
Cells |
Protein |
Glucose |
| ๐งซ TB |
Lymphocytes โ |
โโ |
โ |
| ๐ Cryptococcus |
Lymphocytes โ or few cells |
โ |
โ / normal |
| ๐ฆ Viral |
Lymphocytes โ |
Mild โ |
Usually normal |
| ๐๏ธ Malignant |
Variable |
โ |
Often โ |
| ๐ฅ Inflammatory |
Usually lymphocytes โ |
โ |
Variable |
๐ก Important: CSF findings overlap considerably. A lymphocytic CSF does not automatically mean viral meningitis.
TB, fungal infection, malignancy and inflammatory disease may all produce a lymphocytic pleocytosis.
๐ Management
- ๐งซ Tuberculous meningitis:
- Do not wait for microbiological confirmation if the clinical picture strongly suggests TB meningitis.
- UK NICE guidance recommends isoniazid + rifampicin + pyrazinamide + ethambutol for 2 months, followed by isoniazid + rifampicin for a further 10 months.
- Give adjunctive dexamethasone or prednisolone, tapered gradually over approximately 4โ8 weeks.
- Manage complications such as hydrocephalus, cerebral infarction and tuberculomas with specialist input.
- ๐ Cryptococcal meningitis:
- Requires specialist infectious-disease/microbiology input.
- Induction treatment usually contains liposomal amphotericin B + flucytosine, followed by fluconazole consolidation and maintenance therapy.
- ๐ Raised intracranial pressure is common and must be actively sought.
- Repeated therapeutic lumbar punctures are a key treatment when symptomatic intracranial pressure is elevated; CSF diversion may occasionally be required.
- Routine acetazolamide, mannitol or corticosteroids are not substitutes for CSF pressure control.
- ๐ฆ Other infections:
- Treat according to the identified pathogen and antimicrobial sensitivities.
- Neurosyphilis, neuroborreliosis and other specific infections require targeted antimicrobial regimens.
- HSV-associated meningitis may require antiviral treatment depending on severity and clinical circumstances.
- ๐ฅ Autoimmune / inflammatory meningitis:
- Treatment depends on the underlying disorder and may involve corticosteroids and other immunosuppressive therapy.
- โ ๏ธ Exclude important infectious causes, particularly TB and fungal infection, before substantial immunosuppression whenever possible.
- ๐๏ธ Leptomeningeal malignancy:
- Treatment is individualised according to tumour type and may involve systemic therapy, targeted therapy, radiotherapy and occasionally intrathecal treatment.
- Early oncology and neuro-oncology involvement is appropriate.
- ๐ง Complications:
- Treat seizures appropriately.
- Identify and manage hydrocephalus and raised intracranial pressure.
- Provide rehabilitation for neurological disability.
โ ๏ธ Red Flags
- ๐จ Reduced or deteriorating consciousness.
- ๐จ New focal neurological deficit.
- ๐จ Papilloedema or suspected markedly raised intracranial pressure.
- ๐จ New seizures.
- ๐จ Hydrocephalus on imaging.
- ๐จ Significant immunosuppression.
- ๐จ Suspected TB or cryptococcal meningitis.
๐ Prognosis
- Outcome depends strongly on the underlying cause and speed of diagnosis.
- ๐งซ TB and fungal meningitis may cause death or permanent neurological disability if treatment is delayed.
- ๐ฅ Inflammatory disease may respond well to immunosuppression but can relapse.
- ๐๏ธ Leptomeningeal malignancy usually indicates advanced malignant disease and prognosis is often poor, although this varies considerably with tumour biology and available targeted treatments.
๐ง Key Learning Points
๐ง Chronic meningitis = symptoms โฅ4 weeks.
๐ฆ Think particularly of TB, fungal infection, spirochaetal infection and HIV.
๐ฅ Do not forget neurosarcoidosis, vasculitis and other inflammatory disease.
๐๏ธ Consider leptomeningeal malignancy, especially with multiple cranial neuropathies.
๐ CSF should include opening pressure, cells, protein, glucose and targeted microbiology.
๐ Recurrent bacterial meningitis โ look for a CSF leak, anatomical defect or immune deficiency.
๐ Cryptococcal meningitis โ actively manage raised intracranial pressure.
โ ๏ธ Avoid empirical immunosuppression until important chronic infections have been reasonably excluded.
๐ References
- NICE. Tuberculosis (NG33). Updated guidance.
- Chang CC, et al. Global guideline for the diagnosis and management of cryptococcosis. Lancet Infect Dis. 2024.
- Saylor D, et al. Chronic Meningitis: Diagnostic and Therapeutic Challenges. 2025.
- Baldwin KJ, et al. Chronic Meningitis. Continuum. 2018.